Article Details

Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) Sees Significant Decline in Short Interest

Retrieved on: 2020-10-18 14:00:00

Tags for this article:

Click the tags to see associated articles and topics

Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) Sees Significant Decline in Short Interest. View article details on hiswai:

Excerpt

<div>The <b>biotechnology</b> company reported ($0.70) earnings per share for the quarter, missing the consensus estimate of ($0.57) by ($0.13). Hedge funds and ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up